Blood biomarkers and medication response following group psychotherapy as an add-on treatment in refractory idiopathic myelodysplasia
{{output}}
Background: Refractory anemia is a hallmark of myelodysplastic syndromes (MDSs), a heterogeneous group of clonal hematopoietic stem cell disorders. Approximately 12% of MDS patients are under 50 years old, and nearly 50% exhibit ... ...
